4.5 Article

Deciphering the antitumoral activity of quinacrine: Binding to and inhibition of Bcl-xL

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 19, Issue 6, Pages 1592-1595

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2009.02.020

Keywords

Acridine; Anticancer; Apoptosis; bcl-2; bcl-xL; Fluorescence polarization spectroscopy; Quinacrine

Funding

  1. Spanish Ministry of Science and Innovation (MICINN) [BIO2004-998, BIO2007-60666, CSD2008-00005, BFU2005-09141]

Ask authors/readers for more resources

From the screening of a unique collection of 880 off-patent small organic molecules, we have found that quinacrine inhibits the interaction between a BH3 domain-derived peptide and the antiapoptotic protein Bcl-xL. Nuclear magnetic resonance spectroscopy confirmed that quinacrine binds to the hydrophobic groove that Bcl-xL uses for interacting with the BH3 domain of proapoptotic proteins. This activity can contribute to the anticancer activity of quinacrine. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available